{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "http://www.leo-pharma.com/#organization",
      "name": "LEO Pharma",
      "url": "http://www.leo-pharma.com/",
      "description": "Dersimelagon is being developed for the treatment of rare and severe genetic diseases that cause severe sunlight-induced skin damage and can significantly limit patients’ ability to spend time outdoors. Read more Template for Editorial purpose Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Lorem impsum Learn more A truly global platform dedicated to medical dermatology Building on a century of experience with breakthrough medicines, the broadest global portfolio in medical dermatology, and a proven innovation model — we are powering progres"
    },
    {
      "@type": "WebPage",
      "@id": "https://asg.websdocs.com/directory/business/leo-pharma#asg",
      "name": "LEO Pharma ASG Directory Profile",
      "url": "https://asg.websdocs.com/directory/business/leo-pharma",
      "isPartOf": {
        "@id": "http://www.leo-pharma.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}